Could PD-L1 positivity be associated with venous thrombosis in patients with non-small cell lung cancer?

Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study

(2021) Hirotsugu Kenmotsu et al.   Cancer Medicine

Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review

(2021) Francisco Galeano-Valle et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

(2021) Xiaohan Qian et al.   Frontiers in Oncology

PD-L1 Regulates Inflammation in LPS-Induced Lung Epithelial Cells and Vascular Endothelial Cells by Interacting with the HIF-1α Signaling Pathway

(2021) Shilong Zhao et al.   INFLAMMATION

Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study

(2021) Xavier Deschênes-Simard et al.   THROMBOSIS RESEARCH

Venous thromboembolism in patients with severe lung cancer: a narrative review

(2021) Lin-Xin Zheng et al.   Annals of Palliative Medicine

Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism

(2021) Wenjuan Di et al.   Cancer Management and Research

Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma

(2020) Pegah Mir Seyed Nazari et al.   ESMO Open

Incidence, risk factors and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

(2020) Florian Moik et al.   BLOOD

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

(2020) Rilan Bai et al.   Biomarker Research

Biomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC)

(2019) J. Nicholas Bodor et al.   CANCER

Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients

(2019) Federico Nichetti et al.   Cancers

Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay

(2018) Paul Scorer et al.   Diagnostic Pathology

Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer

(2017) Gen Lin et al.   Oncotarget

PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome

(2017) Hashem O. Alsaab et al.   Frontiers in Pharmacology

Risk factors and prognosis value of venous thromboembolism in patients with advanced non-small cell lung cancer: a case-control study

(2017) Qian Shen et al.   Journal of Thoracic Disease

Epidemiology and risk factors for venous thromboembolism in lung cancer

(2016) Cihan Ay et al.   CURRENT OPINION IN ONCOLOGY

Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung Cancer

(2016) Charlotte Roach et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Clinical models and biochemical predictors of VTE in lung cancer

(2014) M. Roselli et al.   CANCER AND METASTASIS REVIEWS

Prevalence and Associations of VTE in Patients With Newly Diagnosed Lung Cancer

(2014) Yuhui Zhang et al.   CHEST

The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer

(2014) Ramón Rami-Porta et al.   Journal of Thoracic Oncology

Mutations in NSCLC and their link with lung cancer-associated thrombosis: A case-control study

(2013) Luis Corrales-Rodriguez et al.   THROMBOSIS RESEARCH

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States

(2012) Alok A. Khorana et al.   CANCER

Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer

(2012) G.C. Connolly et al.   LUNG CANCER

Prediction of venous thromboembolism in cancer patients

(2010) C. Ay et al.   BLOOD